Clinical Trial Update: Antibacterial Effect and Clinical Performance of Chitosan Modified Glass Ionomer [Phase 3]

View source ↗

Summary

Phase 3 trial assessing antibacterial effect and clinical performance of chitosan-modified glass ionomer in dental caries-related conditions; study status compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dental Caries
• Pulpitis
• Reversible Pulpitis

Drugs mentioned

• Chitosan modified glass ionomer (chitosan-modified glass ionomer)

Snippet

Sponsor: Ain Shams University | Conditions: Reversible Pulpitis, Pulpitis | Phase 3 | Status: COMPLETED